含有氨氯地平、阿托伐他汀和叶酸的组合物的新用途制造技术

本发明专利技术涉及含有氨氯地平或左旋氨氯地平、阿托伐他汀和叶酸的药物组合物在制备治疗高同型半胱氨酸血症或同型半胱氨酸升高的疾病的药物中的用途。氨氯地平或左旋氨氯地平、阿托伐他汀和叶酸合用可进一步降低Ｈｃｙ水平，优于单用药物，表明氨氯地平或左旋氨氯地平、阿托伐他汀和叶酸合用在降低Ｈｃｙ水平，从而减轻Ｈｃｙ损伤上具有协同作用。本发明专利技术提供的组合物发明专利技术创造是治疗Ｈｃｙ的选择，为高同型半胱氨酸的治疗提供更有效的治疗方案。本发明专利技术属于药学领域。

Novel use of compositions comprising amlodipine, atorvastatin, and folic acid

Use of drugs the present invention relates to pharmaceutical compositions comprising amlodipine or amlodipine, atorvastatin and folic acid in preparation for the treatment of hyperhomocysteinemia or homocysteine in disease. Amlodipine or amlodipine and Atorvastatin Combined with folic acid and can further reduce the level of Hcy, compared with single drug, showed that amlodipine or amlodipine, atorvastatin and folic acid combined with low level of Hcy has a synergistic effect, so as to reduce the damage on Hcy. The composition provided by the invention is an alternative for the treatment of Hcy and provides a more effective therapeutic regimen for the treatment of homocysteine. The invention belongs to the field of pharmacy.

【技术实现步骤摘要】

【技术保护点】
含有氨氯地平、阿托伐他汀和叶酸的组合物在制备治疗高同型半胱氨酸血症的药物中的用途。

【技术特征摘要】

【专利技术属性】
技术研发人员：秦献辉，王文艳，于多，徐希平，
申请(专利权)人：北京奥萨医药研究中心有限公司，深圳奥萨医药有限公司，
类型：发明
国别省市：11[中国|北京]